文献速递骨肌心血管腹部MR

定量T2* MRI评估骨髓铁过载:正常参考值与重型地中海贫血患者评估

Quantitative T2* MRI for bone marrow iron overload: normal reference values and assessment in thalassemia major patients.
PubMed 文献 · Radiol Med · 2022-09-10

研究在1.5T MRI上评估骨髓T2*值的可行性和可重复性,并建立健康受试者的正常下限。30名健康受试者和274名重型地中海贫血(TM)患者接受MRI,骨髓T2*正常下限为13 ms,TM患者骨髓T2*显著低于健康人(7.47±5.18 ms vs. 17.08±1.89 ms;p<0.0001),82.8%的TM患者存在病理性骨髓T2*。骨髓T2*与血清铁蛋白和肝铁负荷呈负相关,正常骨髓T2*对心脏铁沉积的阴性预测值为100%。

要点

  • 骨髓T2*正常下限为13 ms,低于此值提示骨髓铁过载。
  • 骨髓T2*可沿用肝脏铁定量序列同时获得,无需额外扫描。
  • 正常骨髓T2*对心脏铁沉积阴性预测值达100%。

关键影像表现/征象

  • 健康受试者骨髓T2*值与年龄和性别无关。
  • TM患者骨髓T2*值显著低于健康受试者(7.47±5.18 ms vs. 17.08±1.89 ms;p<0.0001)。
  • TM患者中82.8%检测到病理性骨髓T2*。
  • TM患者中女性与骨髓T2*值降低相关。

诊断标准与关键数值

  • 骨髓T2*正常下限为13 ms。
  • 血清铁蛋白>536 ng/ml预测病理性骨髓T2*存在。
  • 骨髓T2*与平均血清铁蛋白水平负相关(R=-0.431;P<0.0001)。
  • 骨髓T2*与肝铁负荷负相关(R=-0.215;P<0.0001)。
  • 骨髓T2*与心脏T2*正相关(R=0.143;P=0.018)。

临床应用与阅片要点

  • 可利用肝脏铁定量序列同时测量骨髓T2*,选择L1或L2椎体圆形ROI。
  • 骨髓T2*低于13 ms提示铁过载,需结合血清铁蛋白和肝铁评估。
  • 正常骨髓T2*对心脏铁沉积阴性预测值100%,可辅助排除心脏铁过载。

局限性

  • 未报告多中心验证,仅为单中心研究。
  • 健康受试者样本量较小(30例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We evaluated the feasibility and reproducibility of bone marrow T2* values and established the lower limit of normal in a cohort of healthy subjects. We investigated the clinical correlates of bone marrow T2* values in patients with thalassemia major (TM).

MATERIAL AND METHODS: Thirty healthy subjects and 274 consecutive TM patients (38.96 ± 8.49 years, 151 females) underwent MRI at 1.5T. An axial slice in the upper abdomen was acquired by a T2* gradient-echo multiecho sequence and the T2* value was calculated in a circular region of interest defined in the visible body of the first or second lumbar vertebra. In patients, also liver and heart T2* values were assessed.

RESULTS: In healthy subjects bone marrow T2* values were independent of age and gender. The lower limit of normal for bone marrow T2* was 13 ms. In both healthy subjects and 30 randomly selected patients, the coefficient of variation for inter-operator-reproducibility was < 10%. TM patients exhibited significantly lower bone marrow T2* values than healthy subjects (7.47 ± 5.18 ms vs. 17.08 ± 1.89 ms; p < 0.0001). A pathological bone marrow T2* was detected in 82.8% of TM patients. In TM, the female sex was associated with reduced bone marrow T2* values. Bone marrow T2* values were inversely correlated with mean serum ferritin levels (R = -0.431; P < 0.0001) and hepatic iron load (R = - 0.215; P < 0.0001). A serum ferritin level > 536 ng/ml predicted the presence of a pathological bone marrow T2*. A positive correlation was found between bone marrow and heart T2* values (R = 0.143; P = 0.018). A normal bone marrow T2* showed a negative predictive value of 100% for cardiac iron.

CONCLUSION: Bone marrow T2* measurements can be easily obtained using the same sequences acquired for liver iron quantification and may bring new insights into the pathophysiology of iron deposition; hence, they should be incorporated into clinical practice.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Meloni, Pistoia, Restaino, et al. Quantitative T2* MRI for bone marrow iron overload: normal reference values and assessment in thalassemia major patients. Radiol Med. 2022. PMID: 36087241. doi:10.1007/s11547-022-01554-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。